Skip to main content
. 2024 Oct 15;15:1468229. doi: 10.3389/fimmu.2024.1468229

Figure 2.

Figure 2

Evaluation of the production and characterization of extracellular vesicles derived from breast cancer cells. (A) Nanoparticle-tracking analysis showing the size distribution of extracellular vesicles (EVs) produced by sensitive and resistant MCF-7 and MDA-MB-231 cells treated with tamoxifen (TAM) and doxorubicin (DOX). (B) Additional information about the average size and concentration of EVs per mL. (C) Histogram showing the EV production of each cancer cell per hour. (D) Transmission electron microscopy images of sensitive and resistant EVs from breast cancer cell lines. TAM-R, tamoxifen-resistant; DOX-R, doxorubicin-resistant; ns, non-significant. The bars represent the mean with the standard deviation from three independent experiments.